Bullboard Post History

by Fryinpan

Order by:

PMN	Hay Farmer Hay Famer Unless you have something intelligent and semi articulate to post,... October 31, 2021
PMN	RE:Biogen Phase 1 Phase one actually ended in 2012. Phase 1b ended in March 2015. "... August 30, 2021
PMN	RE:RE:RE:RE:RE:RE:RE:Immmusafe website is back on line!…$$$ Goldie: you offer nothing in the way of intelligent offering. I suggest... August 17, 2021
PMN	RE:RE:RE:RE:RE:Immmusafe website is back on line!…$$$ Wow Goldie, I suggest you need to find another sandbox to play in if that'... August 17, 2021
PMN	RE:Serology Goldtech it is essential that when copying material directly out of the WHO... July 21, 2021
PMN	FDA extends review period for Aducanumab https://seekingalpha.com/news/3656103-biogen-rises-10-after-fda-extends... January 29, 2021
PMN	RE:RE:RE:Market cap of $28.973M “Always do sober what you said you’d do drunk. That will teach you to... November 20, 2020
PMN	Correction: 554500 Bid and 98500 Ask butterfingers November 13, 2020
PMN	5588500 shares Bid; 98500 Ask Interesting and lopsided. November 13, 2020
PMN	The PMN 34 Month and 90 Week Cycles Are Here! It is interesting to note that PMN has experienced a very consistent 34 month... November 13, 2020
PMN	RE:Insider Filings by transaction date.. Encouraging insider activity. That said: where the heck is ... November 10, 2020
PMN	Looks like we could have an edge The current version of the ProMIS-BCNI antibody test achieves 99.90... July 17, 2020
PMN	RE:zacks valuation This post is right on target. I commend responsible analysis, both from... June 10, 2020
PMN	RE:RE:RE:RE:Sachs Presentation HenrySC ... once again these are NOT my words ... these are the words of... January 29, 2020
PMN	RE:RE:RE:Sachs Presentation Professor Dennis Selkoe explains that amyloid beta oligomers - small... January 29, 2020
PMN	ProMIS is uniquely positioned to capitalize Management has done an excellent job developing their pipeline. See the... January 18, 2020
PMN	Nobel Capital Reiterating Outperform Rating and Target New research report – ProMIS Neurosciences (PMN:CA... July 23, 2019
PMN	RE:Tanzi just presented at a major conference HenrySC ... this is an excellent point. Opportunity lost. June 22, 2019
PMN	Neil Cashman : Targeting a-synuclein [April 9,2019] Guest Commentary: Targeting α-synuclein and the pathogenesis of Parkinson’s... April 10, 2019
PMN	Perhaps there is a message here Two weeks and $20 billion after a major failure in Alzheimer’s disease... April 2, 2019

Become a member today, It's free!

Bullboard Post History

by Fryinpan

Hay Farmer

RE:Biogen Phase 1

RE:RE:RE:RE:RE:RE:RE:Immmusafe website is back on line!…$$$

RE:RE:RE:RE:RE:Immmusafe website is back on line!…$$$

RE:Serology

FDA extends review period for Aducanumab

RE:RE:RE:Market cap of $28.973M

Correction: 554500 Bid and 98500 Ask

5588500 shares Bid; 98500 Ask

The PMN 34 Month and 90 Week Cycles Are Here!

RE:Insider Filings by transaction date..

Looks like we could have an edge

RE:zacks valuation

RE:RE:RE:RE:Sachs Presentation

RE:RE:RE:Sachs Presentation

ProMIS is uniquely positioned to capitalize

Nobel Capital Reiterating Outperform Rating and Target

RE:Tanzi just presented at a major conference

Neil Cashman : Targeting a-synuclein [April 9,2019]

Perhaps there is a message here

Featured News Links

Options Trading for Retiring: Key Strategies in Balancing Retirement Income

One Property, One Focus on Advancing this Gold Project in Ontario

Featured Company

Theralase Technologies Inc. V.TLT

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Fryinpan

Featured News Links

Featured Company